Dr. Eric G. Roberts, M.D.
Heart Failure & Transplant Cardiology (Advanced Heart Failure and Transplant Cardiology Physician)
2900 W Oklahoma Ave, 4th Floor Galleria
Milwaukee, WI 53215
Who else practices at this address →
Milwaukee County includes primary care (32% of residents) and mental health (34% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- Wayne State University School of Medicine (2007)
- Years since graduation
- 19
- In the NPI registry since
- 2008
- Medicare patients seen, 2024
- 322
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2007Medical school: Wayne State University School of Medicine
- 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Advanced Heart Failure and Transplant Cardiology Physician primary
WI license 55936 -
Cardiovascular Disease Physician
WI license 55936 -
Internal Medicine Physician
IL license 125053403
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Map: Heart Failure & Transplant Cardiology per capita by county →
Where they work
Hospitals
- Aurora St Lukes Medical Center Milwaukee, WI
- West Allis Memorial Hospital West Allis, WI
- Aurora Medical Center Kenosha Kenosha, WI
- Aurora Medical Center Grafton, WI
- Aurora Memorial Hospital Burlington Burlington, WI
Medical groups
- Aurora Medical Group, Inc. (3,813 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 322
- Services billed
- 612
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 281 | 101 |
| Established patient office or other outpatient visit, 30-39 minutes | 171 | 152 |
| Evaluation of lower heart chamber assist device | 97 | 16 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 72 | 63 |
| Insertion of tube in right heart chambers for measurement | 34 | 29 |
| New patient office or other outpatient visit, 60-74 minutes | 32 | 32 |
| Established patient office or other outpatient visit, 40-54 minutes | 26 | 26 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 17 | 16 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Tadalafil | 666 |
| Orenitram Er (treprostinil diolamine) | 560 |
| Adempas (riociguat) | 374 |
| Opsumit (macitentan) | 341 |
| Torsemide Other prescribers in Milwaukee, WI | 336 |
| Tyvaso Dpi (treprostinil) | 323 |
| Furosemide Other prescribers in Milwaukee, WI | 301 |
| Jardiance (empagliflozin) Other prescribers in Milwaukee, WI | 293 |
| Potassium Chloride Other prescribers in Milwaukee, WI | 277 |
| Ambrisentan | 239 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 4 companies reported 20 payments worth $11,325 in total to this clinician.
| Actelion Pharmaceuticals US, Inc. | $8,078 |
|---|---|
| United Therapeutics Corporation | $3,068 |
| Merck Sharp & Dohme LLC | $141 |
| Sandoz Inc. | $37.89 |
| Compensation for services other than consulting (speaking, faculty) | $9,625 |
|---|---|
| Food and Beverage | $854 |
| Travel and Lodging | $846 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. Aug 29, 2025 | Compensation for services other than consulting (speaking, faculty) UPTRAVI; OPSUMIT · Cardiology | $3,815 |
| United Therapeutics Corporation Nov 27, 2025 | Compensation for services other than consulting (speaking, faculty) REMODULIN · Pulmonary Arterial Hypertension | $1,270 |
| United Therapeutics Corporation May 6, 2025 | Compensation for services other than consulting (speaking, faculty) REMODULIN · Pulmonary Arterial Hypertension | $1,270 |
| Actelion Pharmaceuticals US, Inc. Sep 19, 2025 | Compensation for services other than consulting (speaking, faculty) UPTRAVI; OPSUMIT · Cardiology | $1,090 |
| Actelion Pharmaceuticals US, Inc. Aug 28, 2025 | Compensation for services other than consulting (speaking, faculty) UPTRAVI; OPSUMIT · Cardiology | $1,090 |
| Actelion Pharmaceuticals US, Inc. May 9, 2025 | Compensation for services other than consulting (speaking, faculty) UPTRAVI; OPSUMIT · Cardiology | $1,090 |
| Actelion Pharmaceuticals US, Inc. Aug 28, 2025 | Travel and Lodging UPTRAVI; OPSUMIT · Cardiology · travel to Appleton, WI · in-kind | $835 |
| Actelion Pharmaceuticals US, Inc. Aug 15, 2025 | Travel and Lodging UPTRAVI; OPSUMIT · Cardiology · travel to Appleton, WI · in-kind | $5.50 |
| Actelion Pharmaceuticals US, Inc. Aug 27, 2025 | Travel and Lodging UPTRAVI; OPSUMIT · Cardiology · travel to Appleton, WI · in-kind | $5.50 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 3 industry-funded studies in 2025, from 3 companies. The companies reported $195,037 in research payments for these studies, mostly to the institutions running them.
- A Phase 2, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Sotatercept versus Placebo for the Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension Cpc-PH due to Hea…
Merck Sharp & Dohme LLC - DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
United Therapeutics Corporation · Recruiting · NCT06388421 - BAY 632521, RiOciguAt UseRs Registry The ROAR registry
Bayer HealthCare Pharmaceuticals Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.